MacroGenics (MGNX) Sr. VP Ezio Bonvini Exercises 40,000 Options

What Happened
Ezio Bonvini, Senior Vice President, Research & Chief Scientific Officer at MacroGenics, exercised options to acquire 40,000 shares on 2026-08-17 at an exercise price of $2.60 per share, for a total cash cost of $104,000. The filing indicates the exercise resulted in holding the underlying shares rather than an immediate sale.

Key Details

• Transaction date: 2026-08-17; filing date: 2026-08-18 (timely filing).
• Transaction type/code: M (option exercise/conversion of derivative).
• Shares acquired: 40,000 at $2.60 each; total cost $104,000.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: F1 states this was an "exercise and hold" of options. F2 describes the grant vesting schedule (12.5% vest after 6 months, then 6.25% each quarter thereafter).

Context
This was an exercise of stock options (derivative conversion) with the resulting shares retained by the insider, not sold. The vesting schedule noted in the filing indicates portions of the grant vest over time, which is common for executive compensation. The transaction is factual and routine compensation-related activity; no sale was reported in this filing.